These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 25312729)

  • 1. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.
    Maranhão RC; Leite AC
    Curr Pharm Des; 2015; 21(9):1196-204. PubMed ID: 25312729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapies targeting innate immunity for fighting inflammation in atherosclerosis.
    Mendel I; Yacov N; Harats D; Breitbart E
    Curr Pharm Des; 2015; 21(9):1185-95. PubMed ID: 25312734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
    Hedin U; Matic LP
    J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
    Hamilton JA; Hasturk H; Kantarci A; Serhan CN; Van Dyke T
    Curr Atheroscler Rep; 2017 Nov; 19(12):57. PubMed ID: 29110146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.
    Fredman G; Tabas I
    Am J Pathol; 2017 Jun; 187(6):1211-1221. PubMed ID: 28527709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Progress on the Relationship between Atherosclerosis and Inflammation.
    Zhu Y; Xian X; Wang Z; Bi Y; Chen Q; Han X; Tang D; Chen R
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30142970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
    Shapiro MD; Fazio S
    Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anti-inflammatory strategies in atherosclerosis.
    van der Valk FM; van Wijk DF; Stroes ES
    Curr Opin Lipidol; 2012 Dec; 23(6):532-9. PubMed ID: 23160400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of anti-platelet treatment in atherosclerosis.
    Arazi HC; Badimon JJ
    Curr Pharm Des; 2012; 18(28):4311-25. PubMed ID: 22236116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of anti-inflammatory agents for treatment of atherosclerosis.
    Chistiakov DA; Melnichenko AA; Grechko AV; Myasoedova VA; Orekhov AN
    Exp Mol Pathol; 2018 Apr; 104(2):114-124. PubMed ID: 29378168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proprotein convertase furin/PCSK3 and atherosclerosis: New insights and potential therapeutic targets.
    Ren K; Jiang T; Zheng XL; Zhao GJ
    Atherosclerosis; 2017 Jul; 262():163-170. PubMed ID: 28400053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
    Kottoor SJ; Arora RR
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte fate in atherosclerosis.
    Hilgendorf I; Swirski FK; Robbins CS
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):272-9. PubMed ID: 25538208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications.
    Sterpetti AV
    Curr Atheroscler Rep; 2020 Oct; 22(12):75. PubMed ID: 33025148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.